Artificial Intelligence (AI) is transforming industries, and drug development is no exception. The regulatory lifecycle, a critical part of therapeutic drug development, offers numerous opportunities for AI to streamline processes, reduce errors, and accelerate time to market.How do you effectively incorporate AI into this complex lifecycle? It requires a thoughtful approach and a clear framework to ensure success, which we present here as five key elements.
Commentary
The regulatory lifecycle + AI
Related resources
Newsletter
The Loom: Weave’s quarterly newsletter – October 2025 edition
At Weave, we’re expanding what’s possible for regulatory teams—bringing AI and human expertise together to make drug development faster, more…
Read more
Release note
Veeva Vault Integration AutoUpdate Feature
This quarter, we focused on one goal: helping teams move through regulatory milestones with greater speed, accuracy, and confidence, without…
Read more
Commentary
Human + AI collaboration increases efficiency in regulatory writing: a joint study with Takeda
Weave, in collaboration with Takeda, has published a first-of-its-kind study — Human–AI Collaboration Increases Efficiency in Regulatory Writing. The study compared…
Read more
Product brochure
Data security and privacy
Weave is committed to the highest standards of data security and privacy. Our cloud-based platform supports the full regulatory lifecycle…
Read more